Table 1 Baseline demographic and clinical characteristics of the study patients
Variable | Low Risk Subjects N = 384 | High Risk Subjects N = 120 |
|---|---|---|
Age – yrs | 56.5 ± 12.4 | 53.4 ± 9.02 |
Height – m | 1.60 ± 0.092 | 1.61 ± 0.099 |
Body Weight – kg | 65.19 ± 11.085 | 73.63 ± 14.31 |
BMIa – kg/m2 | 25.5 ± 4.57 | 28.75 ± 5.42 |
Neck Circumference – cm | 35.45 ± 2.652 | 37.41 ± 3.396 |
Waist Circumference – cm | 98.75 ± 10.87 | 105.90 ± 11.28 |
Hip Circumference – cm | 98.85 ± 8.59 | 104.25 ± 9.99 |
Waist to Hip Ratio | 0.99 ± 0.080 | 1.01 ± 0.065 |
Epworth Sleepiness Score | ||
 Lower Normal Daytime Sleepiness | 3.45 ± 1.091 | 3.375 ± 1.025 |
 Higher Normal Daytime Sleepiness | 7.73 ± 1.330 | 7.94 ± 1.279 |
 Mild Excessive Daytime Sleepiness | 11.32 ± 0.476 | 11.77 ± 0.437 |
 Moderate Excessive Daytime Sleepiness | 13.75 ± 0.808 | 13.85 ± 0.834 |
 Severe Excessive Daytime Sleepiness | 17.45 ± 2.018 | 18 ± 1.805 |
Total Therapy Used | 1.27 ± 0.497 | 1.44 ± 0.631 |
Co-morbidities (No.) | ||
 Diabetes | 84 | 33 |
 Sub-Clinical Hypothyroidism | 31 | 17 |
 Dyslipidemia | 12 | 8 |
 Obesity | 12 | 8 |
 NAFLD | 6 | 6 |
 Others | 140 | 26 |